AIM

#4754
AIM ImmunoTech Inc. Common Stock
0.3 9 USD
-7.14%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
0.39
0.39
Faixa anual
0.21
20.35
Mudança diária
-7.14%
Mudança mensal
-23.54%
Mudança em 6 meses
-75.65%
Mudança anual
-95.41%
Fechamento anterior
0.4 2
Open
0.3 9
Mínimo
0.3 9
High
0.3 9
Volume
233
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 5.68 M
  • Employee 21
  • Founded N/A
  • CEO N/A
  • Website www.aimimmuno.com
  • Headquarter Delaware, United States
  • FIGI BBG000JL6Z80
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-0.13
Índice preço/fluxo de caixa
20.76

AIM ImmunoTech Inc. Common Stock

AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees. The company has created an immunomodulatory double stranded RNA drug called Ampligen. It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome.

Notícias